Viewing Study NCT05691361


Ignite Creation Date: 2025-12-24 @ 11:46 AM
Ignite Modification Date: 2025-12-30 @ 6:18 PM
Study NCT ID: NCT05691361
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2022-12-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients
Sponsor: ADARx Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module